- Home
- UBFO vs NTHI Comparison
UBFO vs NTHI Comparison
Compare UBFO & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UBFO | NTHI |
|---|---|---|
| Founded | 1987 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.7M | 178.4M |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | UBFO | NTHI |
|---|---|---|
| Price | $10.46 | $5.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 257.4K | 59.3K |
| Earning Date | 04-17-2026 | 05-19-2026 |
| Dividend Yield | ★ 4.57% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $2,954,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.01 | ★ N/A |
| Revenue Growth | ★ 1.23 | N/A |
| 52 Week Low | $8.11 | $3.20 |
| 52 Week High | $11.52 | $12.99 |
Technical Indicators
Market Signals| Indicator | UBFO | NTHI |
|---|---|---|
| Relative Strength Index (RSI) | 55.01 | 45.70 |
| Support Level | $9.31 | $4.92 |
| Resistance Level | $10.53 | $5.82 |
| Average True Range (ATR) | 0.20 | 0.50 |
| MACD | 0.04 | 0.10 |
| Stochastic Oscillator | 75.00 | 74.03 |
Price Performance
Historical ComparisonAbout UBFO United Security Bancshares
United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.
About NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).